Long-acting agents (semaglutide weekly, dulaglutide, tirzepatide) produce continuous but physiologically attenuated gastric slowing because of tachyphylaxis at the gastric GLP-1 receptor [3]
Inside the membership, we translate this into real life with simple meal templates, check-in prompts, and gentle weekly themes
Patients using off-label Ozempic for weight management a significant share of Canadian GLP-1 users will see the price benefit on the same timeline as diabetes patients
This section explores these benefits, offering insights into why IF has become a popular lifestyle choice for many
Second Natures Wegovy programme combines the medication with support from registered dietitians and a structured habit-change programme, built around the balanced plate model and sustainable changes rather than restrictive dieting
Alternatively, explore our Community to discover new perspectives on Pfizer